According to a research report from CITIC Securities, Ant Group's C-end AI medical application, previously known as 'AQ', has undergone a rebranding to 'Ant Afu', signifying a strategic brand enhancement. This application stands out with three primary features: Firstly, its ability to conduct structured multimodal precise diagnoses; Secondly, its wealth of long-term health data, which fosters greater user loyalty; Thirdly, its vast potential for commercialization within the expansive Alibaba ecosystem. CITIC Securities holds a positive outlook, predicting that major internet companies will harness their AI product expertise, well-established ecosystems, and financial prowess to swiftly capture the market, instill a mindset of relying on AI for home healthcare among users, and forge a nationwide AI medical application that seamlessly integrates medical consultations, health management, and medical purchasing. In the meantime, prominent pharmaceutical e-commerce platforms, with their substantial C-end user bases and comprehensive commercialization frameworks encompassing online consultations, medication purchases, and appointment scheduling, are poised to be the early beneficiaries. Furthermore, continuous policy support is propelling the growth of the AI+medical sector, with anticipated incremental investments expected to fuel demand from both the business (B-end) and government (G-end) sectors.